In a market as competitive as obesity, a society position statement touting a particular product isn't a bad form of recognition. The American Society for Metabolic and Bariatric Surgery (ASMBS; Gainesville, Fla.) published a statement in its journal, Surgery for Obesity and Related Diseases, supporting vagal blocking therapy for obesity, based on a review of clinical results of the Vblock neurometabolic therapy device from Enteromedics Inc. (St. Paul, Minn.).